| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |